Gynecologic Tumor Board–Case-Based Discussion of the Molecular & Treatment Approach Updates for the Management of Endometrial, Vulvar & Cervical Cancers
There have been many recent studies that further differentiate gynecologic cancers and their management relating to pathologic features, such as molecular status.
Category
  • Gynecologic
  • Immunotherapy
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $0.00
Target Delineation in Postoperative Radiotherapy for Head and Neck Cancer After Flap Reconstruction
This paper explains the controversy about including all of a large reconstruction flap in the RT target volume versus only the perimeter of the flap. Available guidelines regarding the issue are reviewed as are outcome studies that inform the subject.
Category
  • Head and Neck
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Moving Beyond Auditory Speech: Improving Equity for Patients and Providers with Diverse Communication Needs
Despite the prevalence of hearing loss or deafness, many physicians are unfamiliar with how best to support patients and colleagues with diverse communication needs.
Category
  • General RO
  • Health Policy/Informatics
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $0.00
Brain Metastases Radiotherapy While Mitigating Radionecrosis and Neurotoxicity in a Community Setting
There are many strategies for managing brain mets with radiotherapy.
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $0.00
Survival (Time-To-Event) Curve Names and Endpoints
This activity provides practitioners with the knowledge needed to interpret survival time analyses.
Category
  • Health Policy/Informatics
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Appropriateness Criteria for Radiotherapy in the Setting of Presumed Early-stage Lung Cancer
This activity provides practitioners with the knowledge of the treatment of lung mass without tissue diagnosis.
Category
  • Thoracic
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Science Highlights 2024: Breast Cancer
This session highlights the most clinically relevant abstracts within the Breast Cancer track of the 2024 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.
Category
  • Central Nervous System
Format
  • Sessions onDemand
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Cost $79.00
Gray Zone - A Blast from the Past: Definitive Management of Favorable Early Stage Hodgkin Lymphoma Ineligible for Systemic Therapy
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.
Category
  • Hematologic
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $0.00
The Hidden Risks of Artificial Intelligence (AI): Biases and Disparities in the Global Development and Deployment of AI for Cancer Care
Artificial intelligence (AI) and machine learning (ML) are beginning to have a dramatic impact on the field of medicine in the domains of clinical decision making, radiation planning and interactions between patients and their medical teams.
Category
  • Health Policy/Informatics
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $0.00
A Randomized Study of Consolidation Chemoradiation (CTRT) versus Observation after first line chemotherapy (CT) in Advanced Gall Bladder Cancers (GBC): Race-GB Study
Management of unresectable gall bladder cancer (GBC) is challenging, and it can be especially so in Low-to-Middle Income Countries (LMIC), as <50% of patients complete the standard 6 cycles of CT.  This article presents the results of a single center, open label, randomized trial evaluating co
Category
  • Gastrointestinal
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
Cost $49.00

Pages